|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SUNDAY, JULY 6, 2008 - PRE-CONFERENCE WORKSHOPS All pre-conference workshops will be held at Fairmount The Queen Elizabeth Hotel. For information on how to register, please go to the Registration section
1. SUPPORTING POLICY DEVELOPMENT IN GENETICS/GENOMICS: WHERE HTA, HSR, PUBLIC HEALTH AND ELSI RESEARCH MEET 9:00 to 17:00 • Registration fees: CAN$65 for HTAi 2008 participants The translational gap between the development of new genetics/genomics research applications and their judicious introduction in clinical practice and public health has been widely recognized. Bridging this gap requires an interdisciplinary research effort. A closer collaboration is therefore needed between researchers from the fields of health technology assessment, health services research, public health and those actively involved in research into the ethical economic, legal and social issues.
The purpose of this workshop is to build up, through concrete examples and more conceptual presentations, an awareness of the points of convergence and the complementarities between the different fields of research and expertise. Presentations will cover the scope of potential applications of genomics research, under the following themes: genetic testing in the clinical setting, emerging technologies, screening, bio-banks, and policy challenges. Areas for further investigation and collaboration will also be explored at the last panel session through invited commentaries and a debate on the overall theme of the day. The proposed programme involves key players from various jurisdictions and research communities, as well as representatives from national and international organizations. It is hoped that a more concerted research approach may emerge with relevance to the development of evidence informed policy in this field. This workshop is organized by APOGEE-NET, a network to support policy in genetics and CanGeneTest Consortium.
Presentations
2. WALK THE TALK: HOW TO APPLY NEW DEVELOPMENTS OF 9:00 to 16:00 • Registration fees: CAN$190 for HTAi 2008 participants - CAN$225 for non-participants Maximum attendance: 80 For further information: mfj@sst.dk
3. SEPARATING THE WHEAT FROM THE CHAFF. 9:00 to 12:00 • Registration fees: CAN$100 The early identification, prioritisation and assessment of emerging health technologies are essential parts of the health technology assessment and policy decision-making process. Our workshop will be a hands-on experience for people who are interested but not experienced in horizon scanning activities and who would like to learn more about the processes of identification and filtration of significant developments, and prioritisation of topics for assessment or policy action. Participants will be given the opportunity to work in small groups and: • Identify emerging health technologies from a range of sources The workshop will be facilitated by experienced members of the English National Horizon Scanning Centre (NHSC), the Canadian Agency for Drugs and Technologies in Health (CADTH) and the Australia and New Zealand Horizon Scanning Network (ANZHSN).
This workshop is organized by National Horizon Scanning Centre. For further information: c.packer@bham.ac.uk 4. DESAFIOS PARA A IMPLANTAÇÃO DE UMA POLITICA DE AVALIAÇÃO E GESTÃO DE TECNOLOGIAS EM SAUDE NO BRASIL 9:00-12:00 • Free admission • Registration required This workshop will be given in Portuguese. No Brasil, o Sistema Único de Saúde (SUS) é uma rede regionalizada e hierarquizada de ações e serviços, gerenciados pelas esferas Federal, Estadual e Municipal. Seus fundamentos são: universalidade, equidade e integralidade. Funciona com orçamento restrito, para atender população de cerca de 190 milhões, com perfil epidemiológico de sobreposição de doenças transmissíveis e crônico-degenarativas. A ATS é recente no Brasil. O uso inadequado de tecnologias, a incorporação acrítica e as pressões do Judiciário geraram a necessidade de o Ministério da Saúde construir a Política Nacional de Gestão de Tecnologias em Saude (PNGTS). O objetivo é promover o uso de evidências cientificas e de análises econômicas na tomada de decisões sobre a inserção e o monitoramento de tecnologias, considerando os diferentes contextos do SUS.
Os objetivos deste Workshop são discutir os desafios (sistema de governança e abordagens para o envolvimento de profissionais, consumidores e das esferas regionais e locais de gestão) e oportunidades (participação social e necessidade de aumentar a qualidade da atenção à saúde) para implementar uma Política em Gestão de Tecnologias em Saúde; trocar experiências e identificar estratégias para aprimorar seu desenvolvimento. Serão apresentados o sistema de saúde do Brasil e a proposta da PNGTS. Depois, seguirá debate sobre os desafios, as oportunidades e as estratégias para sua implantação, com a participação da audiência.
CHALLENGES FOR IMPLEMENTATION OF A POLICY OF EVALUATION AND MANAGEMENT OF HEALTH TECHNOLOGIES IN BRAZIL In Brazil, the Public Health System (SUS) is a regionalized and hierarchized network of initiatives and services, managed by federal, state and municipal authorities. It is based on the principles of universality, equity and completeness. SUS works with a relatively small budget to attend to a population of almost 190 million with complex epidemiological characteristics of chronic and infectious diseases. For further information: ats.decit@saude.gov.br 5. TRANSPARENCY OF DRUG REIMBURSEMENT INITIATIVES 9:00-12:00 • Free admission • Registration required The purpose of the workshop is to explore different approaches to transparency and accountability in drug reimbursement processes. The session will start with an overview of the key stages of drug reimbursement processes (e.g. drug evaluations, expert recommendations and drug plan decisions). Participants will learn about the similarities and differences between different systems around the world and will have the opportunity to work through an example of a reimbursement decision. The second half of the session will focus on approaches for transparency and accountability in drug funding processes and will include a general discussion of issues and options. For further information: peterc@cadth.ca NEW ! 9. HTA 101: Introduction to Health Technology Assessment 9:00-12:00 • Registration fees: CAN$65 • Minumum attendance : 30 This course offers a lively introduction to HTA for those who are new to the field, as well as for those who seek a refresher course. Developed for international participants and updated annually, this course has been a popular feature of HTA meetings for more than 10 years. This pre-conference workshop will strengthen understanding and participation in other sessions of HTAi 2008. Time is included for questions and discussion. Attendees will receive copies of the workshop materials. This course will emphasize adapting HTA approaches for all types of health technologies and across international settings. The main topics to be covered include: TThis workshop is organized by The Lewin Group. For information : clifford.goodman@lewin.com
6. IMPLANTATION DES UNITES D’EVALUATION DES TECHNOLOGIES DE LA SANTE DANS LES CENTRES HOSPITALIERS UNIVERSITAIRES DANS LA FRANCOPHONIE 14:00-17:00 • Registration fees: CAN$45 for HTAi 2008 participants- CAN$135 for non-participants This workshop will be given in French. Cet atelier pratique d’une demi-journée permettra aux participants de connaître les modèles d’organisation de l’évaluation des technologies de la santé développés dans les centres hospitaliers universitaires de la francophonie (européens et québécois). De plus, les panélistes partageront avec les participants leurs expériences, leurs stratégies, les facteurs de réussite ainsi que les retombées et perspectives concernant la mise en place d’une structure pour l’évaluation des technologies de la santé.
This hands-on, half-a-day workshop will enable participants to learn about the various organizational models of Health Technology Assessment developed by teaching hospitals in French-speaking jurisdictions (Europe and Québec). Panellists will share their experience, strategies and success factors with the participants, and will discuss impacts and prospects of setting up a Health Technology Assessment structure.
This workshop is organized by agence d’évaluation des technologies et des modes d’intervention en santé (AETMIS). For further information: reiner.banken@aetmis.gouv.qc.ca Presentations
7. EVALUACION DE TECNOLOGIAS SANITARIAS EN LATINOAMERICA: PERTINENCIA DE LA CREACION DE UNA RED EN EVALUACION DE TECNOLOGIAS SANITARIAS-ETS- PARA LA REGION 14:00-17:00 • Registration fees: CAN$30 This workshop will be given in Spanish. Mediante este taller los asistentes podrán identificar las necesidades existentes en el campo de la evaluación de tecnologías sanitarias en Latinoamérica, así como visualizar de forma general la realidad latinoamericana (Agencias de ETS, productos). Los asistentes podrán presentar sus experiencias personales en el ámbito y formular medidas para resolver las barreras existentes. Se discutirá la pertinencia de la creación de una RED de ETS Latinoamericana. Los Objetivos específicos de este taller preconferencia son: • Presentar una revisión general de los resultados de la encuesta de evaluación de tecnologías sanitarias (ETS) realizada en Latinoamérica
• Reconocer las barreras que impiden un buen funcionamiento de la evaluación de tecnologías sanitariasen América Latina y conocer el trabajo y los productos de diferentes agencias en la región • Promover el intercambio de ideas y experiencias sobre el trabajo en ETS que se realiza en los países hispano-parlantes • Presentar los pasos iniciales y explorar las oportunidades para la creación de una RED de ETS para Latinoamérica.
The participants will be able to identify the existing needs in the field of Health Technology Assessment in Latin America as well as to visualize, in a general way, the Latin American reality (HTA Agencies, actors and products). Participants will exchange work experiences in their context and formulate measures to solve the existing barriers. The appropriateness of establishing a Latin American Network in HTA will be discussed.
The specific objectives of this pre-conference workshop are: • To display the results of the INAHTA survey on HTA needs in Latin America • To recognize the barriers that prevent a goodoperation of HTA in Latin America and to describe the work and different products of the agencies in the region • To promote the exchange of ideas and experiences on HTA production in Spanishspeaking countries • To explore the opportunities of establishing a Latin America HTA Network and if pertinent, initiate its first steps. This workshop is organized by Agence d’évaluation des technologies et des modes d’intervention en santé (AETMIS). For further information: nieves.rodriguez@aetmis.gouv.qc.ca Presentations
8. ENLIGHTENED DEVELOPMENT AND INFORMED DECISION MAKING FOR MEDICAL DEVICES TO IMPROVE USER ACCESS 14:00-17:00 • Free admission • Registration required Medical devices are typically brought to market at high risk by relatively small companies. Whilst their value to users and service providers is often poorly established, medical devices are increasingly subject to the scrutiny of regulatory agencies requiring (various levels of) evidence regarding clinical and safety aspects as well as cost effectiveness of new technologies. This situation presents some real challenges in all stages of device development and after market launch. In this workshop the current role as well as the future potential of HTA to scientifically support well-informed and timely decision making in the rapidly evolving market of medical devices is discussed from the perspective of users, regulators, industry and academics. Specific questions that are addressed include: 1) HTA in the context of multiple users: how to deal with multiple and varying user needs in development and assessment of medical devices? 2) The impact of contextual factors on HTA of medical technologies: an example from the field of healthcare safety 3) Improving user access to valuable medical devices by integrating HTA within the device development cycle 4) The role of HTA in introducing new technologies in a context of (various) reimbursement and procurement regulations. This workshop is organized by Multidisciplinary assessment of Technology centre in Health care For further information: john.wilkinson@abhi.org.uk or martin.buxton@brunel.ac.uk |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||